Basic information Safety Supplier Related

SR-18292

Basic information Safety Supplier Related

SR-18292 Basic information

Product Name:
SR-18292
Synonyms:
  • SR-18292
  • SR-18292; SR 18292; SR18292
  • SR 18292;SR18292
  • 2-Propanol, 1-[(1,1-dimethylethyl)[(4-methylphenyl)methyl]amino]-3-(1H-indol-4-yloxy)-
  • 1-((1H-Indol-4-yl)oxy)-3-(tert-butyl(4-methylbenzyl)amino)propan-2-ol
  • PPARγ coactivator-1α,PGC-1α,Autophagy,SR18292,SR-18292,Inhibitor,inhibit
  • SR-18292, 10 mM in DMSO
  • SR-18292 ,S8528
CAS:
2095432-55-4
MF:
C23H30N2O2
MW:
366.5
Mol File:
2095432-55-4.mol
More
Less

SR-18292 Chemical Properties

Boiling point:
553.6±50.0 °C(Predicted)
Density 
1.132±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
solubility 
DMF: 25 mg/ml; DMSO: 25 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.33 mg/ml; Ethanol: 10 mg/ml
form 
A crystalline solid
pka
13.90±0.20(Predicted)
color 
White to light brown
InChIKey
CMTOYDGVFTZNSM-BTJKTKAUSA-N
SMILES
CC(C)(C)N(CC(O)COC1=CC=CC2=C1C=CN2)CC3=CC=C(C)C=C3.O=C(O)/C=C\C(O)=O
More
Less

Safety Information

WGK Germany 
WGK 3
Storage Class
11 - Combustible Solids
More
Less

SR-18292 Usage And Synthesis

Uses

SR 18292 is a novel selective inhibitor of PGC-1alpha Gluconeogenic Activity.

Biological Activity

SR-18292 is a potent and specific inhibitor of hepatic gluconeogenesis via increased acetylation of PGC-1α and suppression of gluconeogenic gene expression. SR-18292 reduces blood glucose and increases hepatic insulin sensitivity in mouse models of T2D.

in vivo

SR-18292 reduces fasting blood glucose, increases hepatic insulin sensitivity and improves glucose homeostasis in diabetic mice. The high fat diet (HFD) fed mice, a dietary model of obesity and T2D, are treated with SR-18292 (45mg/kg) via I.P. injection for 3 consecutive days and again on day 4 before measuring fasting blood glucose. Strikingly, mice that are treated with SR-18292 have significantly lower levels of fasting blood glucose concentrations compared to matched vehicle-treated control mice. The induction of gluconeogenic gene expression is a regulatory component of the response to fasting. Importantly, gluconeogenic gene expression, specifically that of Pck1, is inhibited in livers isolated from mice treated with SR-18292[1].

SR-18292Supplier

Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070 13913916777;
Email
info@chemlin.com.cn
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 17798518460
Email
cfzhang@aikonchem.com
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn
Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Email
product02@bidepharm.com
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
More
Less